Company intelligence / Profile preview

MedMira

Halifax, Nova Scotia, Canadamedmira.ca ↗

Ownership: Private
Employees: ~52
Development stage: Other

Overview

MedMira’s rapid diagnostic products are commercialized globally for infectious disease testing, including FDA-cleared, Health Canada-approved, CE-marked, and CFDA-cleared products. The company’s RVF platform enables multiplexing with high speed and accuracy for point-of-care settings. Clinical performance has been validated in multiple regulatory environments.

Therapeutic areas: Infectious Diseases
Modalities: DevicePlatform technology
Industry: Protein Biomarker Diagnostics

Partnerships

Strategic business development partners/distributors in various regions; specific names not disclosed

Beyond the preview

Go deeper on MedMira.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedMira.

Explore the full profile